KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Non-Current Liabilities: 2009-2025

Historic Other Non-Current Liabilities for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $4.3 billion.

  • Thermo Fisher Scientific's Other Non-Current Liabilities fell 1.50% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year decrease of 1.50%. This contributed to the annual value of $4.0 billion for FY2024, which is 14.07% down from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Other Non-Current Liabilities of $4.3 billion as of Q3 2025, which was up 0.19% from $4.3 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Other Non-Current Liabilities' 5-year high stood at $4.7 billion during Q2 2022, with a 5-year trough of $3.4 billion in Q2 2021.
  • Its 3-year average for Other Non-Current Liabilities is $4.3 billion, with a median of $4.3 billion in 2025.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Other Non-Current Liabilities surged by 39.14% in 2022, and later declined by 14.07% in 2024.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Other Non-Current Liabilities stood at $4.5 billion in 2021, then dropped by 6.65% to $4.2 billion in 2022, then grew by 9.53% to $4.6 billion in 2023, then dropped by 14.07% to $4.0 billion in 2024, then fell by 1.50% to $4.3 billion in 2025.
  • Its Other Non-Current Liabilities was $4.3 billion in Q3 2025, compared to $4.3 billion in Q2 2025 and $4.0 billion in Q1 2025.